333 related articles for article (PubMed ID: 26086278)
1. Response to rocuronium and its determinants in patients with myasthenia gravis: A case-control study.
Fujimoto M; Terasaki S; Nishi M; Yamamoto T
Eur J Anaesthesiol; 2015 Oct; 32(10):672-80. PubMed ID: 26086278
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
[TBL] [Abstract][Full Text] [Related]
3. [Reversal of rocuronium induced neuromuscular block with sugammadex in a patient with myasthenia gravis].
Nakamori E; Nitahara K; Sugi Y; Katori K; Matsuzaki A; Higa K
Masui; 2013 Aug; 62(8):972-4. PubMed ID: 23984578
[TBL] [Abstract][Full Text] [Related]
4. [Rocuronium vs vecuronium for neuromuscular block during transsternal thymectomy in the patient with myasthenia gravis].
Cordero Escobar I
Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):578-82. PubMed ID: 22263401
[TBL] [Abstract][Full Text] [Related]
5. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
[TBL] [Abstract][Full Text] [Related]
6. Monitoring recovery from rocuronium-induced neuromuscular block using acceleromyography at the trapezius versus the adductor pollicis muscle: an observational trial.
Soltesz S; Stark C; Noé KG; Anapolski M; Mencke T
Can J Anaesth; 2016 Jun; 63(6):709-17. PubMed ID: 26864194
[TBL] [Abstract][Full Text] [Related]
7. Use of Sugammadex in an octagenerian with Myaesthenia Gravis undergoing emergency laporotomy.
Shah D; Dharmarajah A
J Clin Anesth; 2017 Feb; 37():109-110. PubMed ID: 28235495
[TBL] [Abstract][Full Text] [Related]
8. Reversal of neuromuscular block with sugammadex: a comparison of the corrugator supercilii and adductor pollicis muscles in a randomized dose-response study.
Yamamoto S; Yamamoto Y; Kitajima O; Maeda T; Suzuki T
Acta Anaesthesiol Scand; 2015 Aug; 59(7):892-901. PubMed ID: 25962400
[TBL] [Abstract][Full Text] [Related]
9. [Case of anesthesia for thoracoscopic thymectomy in a pediatric patient with myasthenia gravis: reversal of rocuronium-induced neuromuscular blockade with sugammadex].
Takeda A; Kawamura M; Hamaya I; Kitamura H; Muto R; Mitono H
Masui; 2012 Aug; 61(8):855-8. PubMed ID: 22991811
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of neuromuscular blockade in one muscle group alone may not reflect recovery of total muscle function in patients with ocular myasthenia gravis.
Iwasaki H; Takahoko K; Otomo S; Sasakawa T; Kunisawa T; Iwasaki H
Can J Anaesth; 2013 Dec; 60(12):1222-7. PubMed ID: 24092479
[TBL] [Abstract][Full Text] [Related]
11. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients.
Mann R; Blobner M; Jelen-Esselborn S; Busley R; Werner C
Anesthesiology; 2000 Aug; 93(2):346-50. PubMed ID: 10910480
[TBL] [Abstract][Full Text] [Related]
12. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
13. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
14. Severity of Myasthenia Gravis Influences the Relationship between Train-of-four Ratio and Twitch Tension and Run-down of Rat Endplate Potentials.
Takahashi K; Niiya T; Takada Y; Narimatsu E; Yamakage M
Anesthesiology; 2016 Feb; 124(2):369-77. PubMed ID: 26569169
[TBL] [Abstract][Full Text] [Related]
15. Optimal dose of combined rocuronium and cisatracurium during minor surgery: A randomized trial.
Park WY; Choi JC; Yun HJ; Jeon YG; Park G; Choi JB
Medicine (Baltimore); 2018 Mar; 97(10):e9779. PubMed ID: 29517695
[TBL] [Abstract][Full Text] [Related]
16. Infusion requirements and reversibility of rocuronium at the corrugator supercilii and adductor pollicis muscles.
Suzuki T; Mizutani H; Miyake E; Fukano N; Saeki S; Ogawa S
Acta Anaesthesiol Scand; 2009 Nov; 53(10):1336-40. PubMed ID: 19650798
[TBL] [Abstract][Full Text] [Related]
17. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
[TBL] [Abstract][Full Text] [Related]
18. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex.
Yoshida F; Suzuki T; Kashiwai A; Furuya T; Konishi J; Ogawa S
Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
Xue F; Zhang Y; Liao X; Liu J; An G
Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
[TBL] [Abstract][Full Text] [Related]
20. Magnesium sulfate reduces the rocuronium dose needed for satisfactory double lumen tube placement conditions in patients with myasthenia gravis.
Fei S; Xia H; Chen X; Pang D; Xu X
BMC Anesthesiol; 2019 Aug; 19(1):170. PubMed ID: 31472669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
